Hemophilia in the cath lab: Balancing the need to clot with the treatment of thrombosis.

ABSTRACT

Hemophilia is a rare genetic disorder that inherently results in bleeding risks that can be successfully managed in the cardiac catheterization laboratory. Standard of care options such as drug-coated stents should not be denied hemophiliacs solely on the basis of their genetic defect. Successful care of hemophilia requires a close collaboration with a specialist in these bleeding disorders to optimize care.